November 20, 2020
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Alan Campbell
| RE: | Immunic, Inc. Registration Statement on Form S-3 File No. 333-250083 Filed November 13, 2020 |
In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Immunic, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Tuesday, November 24, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.
Please call Ilan Katz of Dentons US LLP at (212) 632-5556 to confirm the effectiveness of the Registration Statement or with any questions.
| Very truly yours, | |
| Immunic, Inc. | |
| /s/ Daniel Vitt | |
| Daniel Vitt | |
| President and Chief Executive Officer |
